Cleared Traditional

K183238 - BeneVision Central Monitoring System (FDA 510(k) Clearance)

Mar 2019
Decision
113d
Days
Class 2
Risk

K183238 is an FDA 510(k) clearance for the BeneVision Central Monitoring System. This device is classified as a System, Network And Communication, Physiological Monitors (Class II - Special Controls, product code MSX).

Submitted by Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on March 13, 2019, 113 days after receiving the submission on November 20, 2018.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2300.

Submission Details

510(k) Number K183238 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 20, 2018
Decision Date March 13, 2019
Days to Decision 113 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MSX — System, Network And Communication, Physiological Monitors
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2300